Search

Your search keyword '"Ghiani, M"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Ghiani, M" Remove constraint Author: "Ghiani, M" Publisher elsevier bv Remove constraint Publisher: elsevier bv
42 results on '"Ghiani, M"'

Search Results

24. Cetuximab + platinum-based therapy (PBT) as a first-line treatment for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): An observational study (ENCORE)

25. Skin rash and response to cetuximab treatment: a retrospective single-center analysis

26. The observational ENCORE study: Cetuximab + platinum-based therapy (PBT) for first-line (1L) treatment of patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

27. Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study

29. PCDD/F and PCB multi-media ambient concentrations, congener patterns and occurrence in a Mediterranean coastal lagoon (Etang de Thau, France)

30. Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)

34. Chemoimmunotherapy with weekly cisplatin and etoposide plus S.C. rIL-2 plus oral medroxyprogesterone acetate (MPA) in stage IIIB-IV NSCLC: Preliminary results on clinical response and on immunologic assessment

35. 297 Chemoimmunotherapy with weekly cisplatin and etoposide plus S.C. rIL-2 plus oral medroxyprogesterone acetate (MPA) in stage IIIB-IV NSCLC: Preliminary results on clinical response and on immunologic assessment

36. Chemoimmunotherapy with weekly cisplatin and etoposide plus S.C. rIL-2 plus oral medroxyprogesterone acetate (MPA) in stage HIB-IV NSCLC: Preliminary results on clinical response and on immunologic assessment

37. Neo-adjuvant chemo-(immuno-) therapy of advanced head and neck squamous cell carcinoma (HNSCC): A multicenter phase III randomized study comparing cisplatin (CDDP) + 5-FU with CDDP + 5-FU + recombinant interleukin 2 (rIL 2): Preliminary results

40. 1206 Comparison of granisetron vs ondansetron vs tropisetron in the prophylaxis of acute nausea and vomiting induced by highly emetogenic chemotherapy (high-dose cisplatin) for treatment of primary head and neck cancer: An open cross-over randomized controlled trial (RCT)

41. Abdominal and pelvic stop-flow (hypoxic, chemotherapeutic loco-regional treatment): Preliminary report of a phase I study

42. Developmental expression of the T-box transcription factor T-bet/Tbx21 during mouse embryogenesis

Catalog

Books, media, physical & digital resources